Vincent

Gureghian

PhD

Biography:

Originating from France, Dr. Gureghian earned a Bachelor's degree in Life Sciences with a minor in Physical Chemistry from the University of Evry, now part of Paris-Saclay University. In 2016, he participated in the iGEM competition and defended his team's project at the Giant Jamboree held in Boston, MA, USA.

Dr. Gureghian then pursued a Master's degree in Systems and Synthetic Biology. In 2017, he founded and led the Evry Paris-Saclay team for the iGEM competition. The year after, he did a six-month internship at ETH Zurich where he combined experimental and computational efforts to tune a biophysical model of bacterial operons.

In 2019, Dr. Gureghian joined a PhD program in the Department of Life Science and Medicine at the University of Luxembourg. There, he acquired and analyzed molecular and omics data to understand how cancer cells adapt to treatments. During this time, he collaborated with the Przulj Lab at the Barcelona Supercomputing Center to integrate omics data into molecular network models. He successfully defended his thesis, titled "Contribution of Transposable Elements to Drug Resistance in Melanoma" in November 2023.

In 2024, Dr. Gureghian joined the Najjar lab in the Department of Rheumatology at the University of Washington. He now contributes to research on rheumatic diseases by performing computational analyses on patient data to generate novel hypotheses and guide experimental design. He has a special interest in senescence, repeat sequences and related immunity. He is excited to contribute in unveiling the cellular and physiological consequences of these largely unexplored portions of the genome using statistical and deep learning methods.